 | 2009 (Vol. 29): Issue 4 2009 (313-408)
|
 | 1. | In eigener Sache: Plädoyer für praxisbezogene Übersichten sowie Pro und Kontra Ergebnisse der Leserbefragung |
A. Schürg Hämostaseologie 2009 29 4: 313-313 | ||
| [Summary] [Free download] | ||
| 2. | ||
M. Moser (1), C. Bode (2) (1) Universität Freiburg; (2) Department of Internal Medicine III (Cardiology), University of Freiburg, Germany Hämostaseologie 2009 29 4: 319-319 | ||
| [Summary] [Free download] | ||
| 3. | Antiplatelet therapy after coronary intervention in Asia and Japan The Asian perspective of antiplatelet intervention | |
S. Goto (1), E. Toda (1) (1) Department of Medicine (Cardiology), Tokai University School of Medicine, Japan Hämostaseologie 2009 29 4: 321-325 | ||
| [Summary] [Free download] | ||
| 4. | Antiplatelet agents in stroke prevention Acute and long-term treatment strategies | |
R. Weber (1), C. Weimar (1), H.-C. Diener (1) (1) Department of Neurology and Stroke Center, University Duisburg-Essen, Essen, Germany Hämostaseologie 2009 29 4: 326-333 | ||
| [Summary] [Free download] | ||
| 5. | Glycoprotein IIb/IIIa antagonists New developments | |
U. Zeymer (1), R. Zahn (1) (1) Herzzentrum Ludwigshafen und Institut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg Hämostaseologie 2009 29 4: 334-337 | ||
| [Summary] [Free download] | ||
| 6. | |
Hämostaseologie 2009 29 4: 338-338 | ||
| [Summary] [Free download] | ||
| 7. | P2Y12 inhibitors Thienopyridines and direct oral inhibitors | |
J.-P. Collet (1), G. Montalescot (1) (1) INSERM U937 Unit, Institut de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France Hämostaseologie 2009 29 4: 339-348 | ||
| [Summary] [Free download] | ||
| 8. | Improving antiplatelet therapy for atherothrombotic disease Preclinical and clinical results with SCH 530348, the first oral thrombin receptor antagonist selective for PAR-1 | |
S. K. Hildemann (1), C. Bode (2) (1) Essex Pharma GmbH, Munich, Germany; (2) Department of Internal Medicine III (Cardiology), University of Freiburg, Germany Hämostaseologie 2009 29 4: 349-355 | ||
| [Summary] [Free download] | ||
| 9. | |
D. Duerschmied (1), C. Bode (1) (1) Kardiologie und Angiologie, Universitätsklinikum Freiburg Hämostaseologie 2009 29 4: 356-359 | ||
| [Summary] [Free download] | ||
| 10. | Individualized antiplatelet therapy What can a clinical score contribute? | |
T. Geisler (1), M. Gawaz (1) (1) Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Universitätsklinikum der Eberhard-Karls-Universität Tübingen Hämostaseologie 2009 29 4: 360-367 | ||
| [Summary] [Free download] | ||
| 11. | Platelet monitoring for PCI Is it really necessary? | |
U. S. Tantry (1), P. A. Gurbel (1) (1) Sinai Center for Thrombosis Research, Baltimore, Maryland, USA Hämostaseologie 2009 29 4: 368-375 | ||
| [Summary] [Free download] | ||
| 12. | Platelet monitoring for PCI Which test is the one to choose? | |
D. Capodanno (1), D. J. Angiolillo (1) (1) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA Hämostaseologie 2009 29 4: 376-380 | ||
| [Summary] [Free download] | ||
| 13. | Acute coronary syndromes and percutaneous coronary interventions Impact of bleeding and blood transfusion | |
J.-P. Bassand (1) (1) Department of Cardiology, University Hospital Jean Minjoz, Besançon, France Hämostaseologie 2009 29 4: 381-387 | ||
| [Summary] [Free download] | ||
| 14. | Management of bleeding in patients using antithrombotic agents Prediction, prevention, protection and problem-oriented intervention | |
R. E. Scharf (1) (1) Institut für Experimentelle und Klinische Hämostaseologie, Hämotherapie und Transfusionsmedizin, Universitätsklinikum Düsseldorf, und Biologisch-Medizinisches Forschungszentrum der Heinrich-Heine-Universität Düsseldorf Hämostaseologie 2009 29 4: 388-398 | ||
| [Summary] [Free download] | ||
